Bryn Mawr Trust CO Procept Bio Robotics Corp Transaction History

Bryn Mawr Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 28, 2025	BUY	$35.69 - $60.06 $535 - $900	15 Added 68.18%	37 $1,000
Q2 2025 Jul 28, 2025	SELL	$48.82 - $65.05 $51,993 - $69,278	-1,065 Reduced 97.98%	22 $1,000
Q1 2025 May 08, 2025	BUY	$56.03 - $88.57 $18,097 - $28,608	323 Added 42.28%	1,087 $63,000
Q4 2024 Jan 28, 2025	SELL	$67.27 - $99.45 $2,018 - $2,983	-30 Reduced 3.78%	764 $61,000
Q3 2024 Nov 25, 2024	BUY	$56.31 - $84.99 $44,710 - $67,482	794 New	794 $63,000

272

49.1M

274K

376K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.32B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

Stay updated on Bryn Mawr Trust CO with notifications on news.